Phytoestrogen suppresses efflux of the diagnostic marker protoporphyrin IX in lung carcinoma

Hirofumi Fujita, Keisuke Nagakawa, Hirotsugu Kobuchi, Tetsuya Ogino, Yoichi Kondo, Keiji Inoue, Taro Shuin, Toshihiko Utsumi, Kozo Utsumi, Junzo Sasaki, Hideyo Ohuchi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

One promising method to visualize cancer cells is based on the detection of the fluorescent photosensitizer protoporphyrin IX (PpIX) synthesized from 5-aminolevulinic acid (ALA), but this method cannot be used in cancers that exhibit poor PpIX accumulation. PpIX appears to be pumped out of cancer cells by the ABC transporter G2 (ABCG2), which is associated with multidrug resistance. Genistein is a phytoestrogen that appears to competitively inhibit ABCG2 activity. Therefore, we investigated whether genistein can promote PpIX accumulation in human lung carcinoma cells. Here we report that treatment of A549 lung carcinoma cells with genistein or a specific ABCG2 inhibitor promoted ALA-mediated accumulation of PpIX by approximately 2-fold. ABCG2 depletion and overexpression studies further revealed that genistein promoted PpIX accumulation via functional repression of ABCG2. After an extended period of genistein treatment, a significant increase in PpIX accumulation was observed in A549 cells (3.7-fold) and in other cell lines. Systemic preconditioning with genistein in a mouse xenograft model of lung carcinoma resulted in a 1.8-fold increase in accumulated PpIX. Long-term genistein treatment stimulated the expression of genes encoding enzymes involved in PpIX synthesis, such as porphobilinogen deaminase, uroporphyrinogen decarboxylase, and protoporphyrinogen oxidase. Accordingly, the rate of PpIX synthesis was also accelerated by genistein pretreatment. Thus, our results suggest that genistein treatment effectively enhances ALA-induced PpIX accumulation by preventing the ABCG2-mediated efflux of PpIX from lung cancer cells and may represent a promising strategy to improve ALA-based diagnostic approaches in a broader set of malignancies.

Original languageEnglish
Pages (from-to)1837-1846
Number of pages10
JournalCancer Research
Volume76
Issue number7
DOIs
Publication statusPublished - Apr 1 2016

Fingerprint

Phytoestrogens
Photosensitizing Agents
Genistein
Carcinoma
Lung
ATP-Binding Cassette Transporters
Aminolevulinic Acid
protoporphyrin IX
Neoplasms
Protoporphyrinogen Oxidase
Uroporphyrinogen Decarboxylase
Hydroxymethylbilane Synthase
Multiple Drug Resistance
Heterografts
Lung Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Phytoestrogen suppresses efflux of the diagnostic marker protoporphyrin IX in lung carcinoma. / Fujita, Hirofumi; Nagakawa, Keisuke; Kobuchi, Hirotsugu; Ogino, Tetsuya; Kondo, Yoichi; Inoue, Keiji; Shuin, Taro; Utsumi, Toshihiko; Utsumi, Kozo; Sasaki, Junzo; Ohuchi, Hideyo.

In: Cancer Research, Vol. 76, No. 7, 01.04.2016, p. 1837-1846.

Research output: Contribution to journalArticle

Fujita, H, Nagakawa, K, Kobuchi, H, Ogino, T, Kondo, Y, Inoue, K, Shuin, T, Utsumi, T, Utsumi, K, Sasaki, J & Ohuchi, H 2016, 'Phytoestrogen suppresses efflux of the diagnostic marker protoporphyrin IX in lung carcinoma', Cancer Research, vol. 76, no. 7, pp. 1837-1846. https://doi.org/10.1158/0008-5472.CAN-15-1484
Fujita, Hirofumi ; Nagakawa, Keisuke ; Kobuchi, Hirotsugu ; Ogino, Tetsuya ; Kondo, Yoichi ; Inoue, Keiji ; Shuin, Taro ; Utsumi, Toshihiko ; Utsumi, Kozo ; Sasaki, Junzo ; Ohuchi, Hideyo. / Phytoestrogen suppresses efflux of the diagnostic marker protoporphyrin IX in lung carcinoma. In: Cancer Research. 2016 ; Vol. 76, No. 7. pp. 1837-1846.
@article{fa7d6150b1fb48d0bc6a4318e860fb05,
title = "Phytoestrogen suppresses efflux of the diagnostic marker protoporphyrin IX in lung carcinoma",
abstract = "One promising method to visualize cancer cells is based on the detection of the fluorescent photosensitizer protoporphyrin IX (PpIX) synthesized from 5-aminolevulinic acid (ALA), but this method cannot be used in cancers that exhibit poor PpIX accumulation. PpIX appears to be pumped out of cancer cells by the ABC transporter G2 (ABCG2), which is associated with multidrug resistance. Genistein is a phytoestrogen that appears to competitively inhibit ABCG2 activity. Therefore, we investigated whether genistein can promote PpIX accumulation in human lung carcinoma cells. Here we report that treatment of A549 lung carcinoma cells with genistein or a specific ABCG2 inhibitor promoted ALA-mediated accumulation of PpIX by approximately 2-fold. ABCG2 depletion and overexpression studies further revealed that genistein promoted PpIX accumulation via functional repression of ABCG2. After an extended period of genistein treatment, a significant increase in PpIX accumulation was observed in A549 cells (3.7-fold) and in other cell lines. Systemic preconditioning with genistein in a mouse xenograft model of lung carcinoma resulted in a 1.8-fold increase in accumulated PpIX. Long-term genistein treatment stimulated the expression of genes encoding enzymes involved in PpIX synthesis, such as porphobilinogen deaminase, uroporphyrinogen decarboxylase, and protoporphyrinogen oxidase. Accordingly, the rate of PpIX synthesis was also accelerated by genistein pretreatment. Thus, our results suggest that genistein treatment effectively enhances ALA-induced PpIX accumulation by preventing the ABCG2-mediated efflux of PpIX from lung cancer cells and may represent a promising strategy to improve ALA-based diagnostic approaches in a broader set of malignancies.",
author = "Hirofumi Fujita and Keisuke Nagakawa and Hirotsugu Kobuchi and Tetsuya Ogino and Yoichi Kondo and Keiji Inoue and Taro Shuin and Toshihiko Utsumi and Kozo Utsumi and Junzo Sasaki and Hideyo Ohuchi",
year = "2016",
month = "4",
day = "1",
doi = "10.1158/0008-5472.CAN-15-1484",
language = "English",
volume = "76",
pages = "1837--1846",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "7",

}

TY - JOUR

T1 - Phytoestrogen suppresses efflux of the diagnostic marker protoporphyrin IX in lung carcinoma

AU - Fujita, Hirofumi

AU - Nagakawa, Keisuke

AU - Kobuchi, Hirotsugu

AU - Ogino, Tetsuya

AU - Kondo, Yoichi

AU - Inoue, Keiji

AU - Shuin, Taro

AU - Utsumi, Toshihiko

AU - Utsumi, Kozo

AU - Sasaki, Junzo

AU - Ohuchi, Hideyo

PY - 2016/4/1

Y1 - 2016/4/1

N2 - One promising method to visualize cancer cells is based on the detection of the fluorescent photosensitizer protoporphyrin IX (PpIX) synthesized from 5-aminolevulinic acid (ALA), but this method cannot be used in cancers that exhibit poor PpIX accumulation. PpIX appears to be pumped out of cancer cells by the ABC transporter G2 (ABCG2), which is associated with multidrug resistance. Genistein is a phytoestrogen that appears to competitively inhibit ABCG2 activity. Therefore, we investigated whether genistein can promote PpIX accumulation in human lung carcinoma cells. Here we report that treatment of A549 lung carcinoma cells with genistein or a specific ABCG2 inhibitor promoted ALA-mediated accumulation of PpIX by approximately 2-fold. ABCG2 depletion and overexpression studies further revealed that genistein promoted PpIX accumulation via functional repression of ABCG2. After an extended period of genistein treatment, a significant increase in PpIX accumulation was observed in A549 cells (3.7-fold) and in other cell lines. Systemic preconditioning with genistein in a mouse xenograft model of lung carcinoma resulted in a 1.8-fold increase in accumulated PpIX. Long-term genistein treatment stimulated the expression of genes encoding enzymes involved in PpIX synthesis, such as porphobilinogen deaminase, uroporphyrinogen decarboxylase, and protoporphyrinogen oxidase. Accordingly, the rate of PpIX synthesis was also accelerated by genistein pretreatment. Thus, our results suggest that genistein treatment effectively enhances ALA-induced PpIX accumulation by preventing the ABCG2-mediated efflux of PpIX from lung cancer cells and may represent a promising strategy to improve ALA-based diagnostic approaches in a broader set of malignancies.

AB - One promising method to visualize cancer cells is based on the detection of the fluorescent photosensitizer protoporphyrin IX (PpIX) synthesized from 5-aminolevulinic acid (ALA), but this method cannot be used in cancers that exhibit poor PpIX accumulation. PpIX appears to be pumped out of cancer cells by the ABC transporter G2 (ABCG2), which is associated with multidrug resistance. Genistein is a phytoestrogen that appears to competitively inhibit ABCG2 activity. Therefore, we investigated whether genistein can promote PpIX accumulation in human lung carcinoma cells. Here we report that treatment of A549 lung carcinoma cells with genistein or a specific ABCG2 inhibitor promoted ALA-mediated accumulation of PpIX by approximately 2-fold. ABCG2 depletion and overexpression studies further revealed that genistein promoted PpIX accumulation via functional repression of ABCG2. After an extended period of genistein treatment, a significant increase in PpIX accumulation was observed in A549 cells (3.7-fold) and in other cell lines. Systemic preconditioning with genistein in a mouse xenograft model of lung carcinoma resulted in a 1.8-fold increase in accumulated PpIX. Long-term genistein treatment stimulated the expression of genes encoding enzymes involved in PpIX synthesis, such as porphobilinogen deaminase, uroporphyrinogen decarboxylase, and protoporphyrinogen oxidase. Accordingly, the rate of PpIX synthesis was also accelerated by genistein pretreatment. Thus, our results suggest that genistein treatment effectively enhances ALA-induced PpIX accumulation by preventing the ABCG2-mediated efflux of PpIX from lung cancer cells and may represent a promising strategy to improve ALA-based diagnostic approaches in a broader set of malignancies.

UR - http://www.scopus.com/inward/record.url?scp=84963973732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963973732&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-15-1484

DO - 10.1158/0008-5472.CAN-15-1484

M3 - Article

C2 - 26837765

AN - SCOPUS:84963973732

VL - 76

SP - 1837

EP - 1846

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 7

ER -